USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
U.S. Alzheimer's Disease Medications Markets
U.S. Alzheimer's Disease Medications Markets
RELEASE DATE
18-Nov-2003
18-Nov-2003
REGION
North America
North America
Research Code: A636-01-00-00-00
SKU: HC00928-NA-MR_04754
$2,450.00
Special Price $1,837.50 save 25 %
In stock
SKU
HC00928-NA-MR_04754
Description
The U.S. Alzheimer's Disease Medications market report provides revenue forecasts, patient forecasts, pricing forecasts, competitive analysis, market trends, and product analysis. The market is segmented into mild to moderate, moderate to severe, and mild cognitive impairment Alzheimer's disease. Each of the segments discusses discusses all these in detail along with product pipeline and competitive structure.
Table of Contents
Executive Summary
- Executive Summary
Introduction
- Report Scope and Segmentation
- Disease Overview
- Prevalence and Incidence
- Clinical Presentation
- Neurological Impact
- Diagnosis
Pharmacological Treatments
- Pharmacological Treatments Guidelines
- Cognitive Treatments
- Behavioral Treatments
- Preventative Treatments
Overview
Demand Analysis
- Introduction
- Current Treatments and Market Participants
- Top Industry Challenges
Historical Market Analysis:1998-2002
- Total Prevalence Forecasts
- Adjusted Prevalence Forecasts
- Demand Analysis: Conclusions and Implications
Research and Development Activities
- Market Dynamics
- Product Analysis
- Product Pricing Analysis
- Technology and Market Trends
Market Forecasts: 2003-2010
- Research and Development Areas of Focus
- Acetylcholinesterase Inhibitors
- Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
- Estrogen Replacement Therapy/Hormone Replacement Therapy (ERT/HRT)
- Nerve Growth Factors
- NMDA Receptor Antagonists
- Other Research Areas
- Phase I to Phase III Trials
Frost & Sullivan Awards
- Baseline Market Forecasts: 2003-2010
- Market Drivers and its Impact on Future Revenues
- Market Restraints and Its Impact on Future Revenues
- Event-Based Forecasts
- Market Engineering Analysis
Segment Highlights
Market Dynamics
Market Revenue Forecasts: 2003-2010
Segment Highlights
Market Dynamics
Market Revenue Forecast: 2003-2010
Segment Highlights
Market Dynamics
Market Revenue Forecast: 2003-2010
Physician Survey
Decision Support Database
Popular Topics
The U.S. Alzheimer's Disease Medications market report provides revenue forecasts, patient forecasts, pricing forecasts, competitive analysis, market trends, and product analysis. The market is segmented into mild to moderate, moderate to severe, and mild cognitive impairment Alzheimer's disease. Each of the segments discusses discusses all these in detail along with product pipeline and competitive structure.
| No Index | Yes |
|---|---|
| Podcast | No |
| Industries | Healthcare |
| WIP Number | A636-01-00-00-00 |
| Is Prebook | No |